CymaBay Therapeutics Inc. (CBAY) Reports Q4 Loss, Misses Revenue Estimates

CymaBay Therapeutics Inc. (CBAY) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to loss of $0.30 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -9.38%. A quarter ago, it was expected that this company would post a loss of $0.30 per share when it actually produced a loss of $0.32, delivering a surprise of -6.67%.Over the last four quarters, the company ha ...